Featured Research

from universities, journals, and other organizations

New Tool For Predicting Drug Responsiveness In Non–small Cell Lung Cancer

Date:
May 18, 2009
Source:
Journal of Clinical Investigation
Summary:
Scientists have developed a new genomics approach that enabled them to predict whether non–small cell lung cancers (NSCLCs) will respond to specific therapeutics in vitro and in mouse models of lung cancer.

A team of researchers, at the Max Planck Institute for Neurological Research, Germany, and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, has developed a new genomics approach that enabled them to predict whether non–small cell lung cancers (NSCLCs) will respond to specific therapeutics in vitro and in mouse models of lung cancer.

Related Articles


They hope that this information can be translated into clinical practice.

The team, led by Roman Thomas, Kwok-Kin Wong, and Matthew Meyerson, determined that the genomes of a large panel of human NSCLC cell lines are highly representative of those of primary NSCLC tumors. Using this panel of cell lines they identified genomic and molecular indicators of a response to clinically relevant drugs.

For example, cell lines with an increased number of copies of the ABL2 gene and/or an increased number of copies of the Ephrin receptor kinase and SRC kinase family genes were sensitive to treatment with a clinically used SRC/ABL inhibitor (dasatinib), both in vitro and when they were xenografted into mice.

he authors suggest that the cell line collection characterized here will provide a tool for investigating the effect of potential new anticancer drugs in genomically defined cancer types and thereby help define the patients for which a drug will be most effective.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Journal Reference:

  1. Predicting drug susceptibility of non%u2013small cell lung cancers based on genetic lesions. Journal of Clinical Investigation, May 18, 2009

Cite This Page:

Journal of Clinical Investigation. "New Tool For Predicting Drug Responsiveness In Non–small Cell Lung Cancer." ScienceDaily. ScienceDaily, 18 May 2009. <www.sciencedaily.com/releases/2009/05/090518172448.htm>.
Journal of Clinical Investigation. (2009, May 18). New Tool For Predicting Drug Responsiveness In Non–small Cell Lung Cancer. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2009/05/090518172448.htm
Journal of Clinical Investigation. "New Tool For Predicting Drug Responsiveness In Non–small Cell Lung Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/05/090518172448.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins